Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
36%
OVERLAP
BY WEIGHT
54
# OF OVERLAPPING
HOLDINGS
BBP
65
HOLDINGS
89%
ALSO IN IBB
IBB
256
HOLDINGS
25%
ALSO IN BBP
SECTOR DRIFT (BBP minus IBB)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BBP |
Weight in IBB |
Overlap | |
---|---|---|---|---|
GILEAD SCIENCES INC | 2.1% | 7.7% | 2.1% | |
AMGEN INC | 2.0% | 7.4% | 2.0% | |
VERTEX PHARMACEUTICALS INC | 1.7% | 7.7% | 1.7% | |
INSMED INC | 1.7% | 2.1% | 1.7% | |
ALNYLAM PHARMACEUTICALS INC | 1.6% | 4.7% | 1.6% |
BBP Overweight Relative to IBB
INTRA-CELLULAR THERAPIES INC | 2.6% | |
SAGE THERAPEUTICS INC | 2.1% | |
TG THERAPEUTICS INC | 2.1% | |
ZAI LAB LTD. UNSPONSORED ADR | 2.0% | |
HARMONY BIOSCIENCES HOLDINGS, INC. | 1.7% | |
SPRINGWORKS THERAPEUTICS, INC. | 1.7% | |
DYNAVAX TECHNOLOGIES CORP | 1.7% | |
LIGAND PHARMACEUTICALS-CL B | 1.7% | |
ARDELYX INC | 1.7% | |
AXSOME THERAPEUTICS, INC. | 1.6% |
BBP Underweight Relative to IBB
VERTEX PHARMACEUTICALS INC | -5.9% | |
GILEAD SCIENCES INC | -5.6% | |
AMGEN INC | -5.4% | |
REGENERON PHARMACEUTICALS | -4.8% | |
IQVIA HOLDINGS INC | -3.2% | |
ALNYLAM PHARMACEUTICALS INC | -3.1% | |
METTLER-TOLEDO INTERNATIONAL | -2.9% | |
NATERA INC | -2.6% | |
ARGENX SE ADR | -2.5% | |
WATERS CORP | -2.5% |